Peripheral Vascular Diseases: Clinical Trials

2,075 trials for Peripheral Vascular Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1110 completed, 407 unknown, 193 recruiting, 135 terminated. 886 Not applicable, 230 Phase 2, 172 Phase 3, 145 Phase 4, 141 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable886Completed 465, Unknown 160, Recruiting 100, Terminated 54, Not yet recruiting 37, Active not recruiting 36, Withdrawn 28, Suspended 4, Enrolling by invitation 2
Phase 2230Completed 134, Unknown 49, Terminated 22, Withdrawn 9, Not yet recruiting 7, Recruiting 7, Active not recruiting 2
Phase 3172Completed 101, Unknown 32, Terminated 17, Recruiting 11, Not yet recruiting 4, Withdrawn 4, Active not recruiting 3
Phase 4145Completed 81, Unknown 32, Terminated 13, Recruiting 8, Withdrawn 5, Not yet recruiting 3, Active not recruiting 2, Suspended 1
Phase 1141Completed 80, Unknown 34, Terminated 10, Withdrawn 8, Not yet recruiting 4, Active not recruiting 3, Recruiting 2
Early Phase 124Completed 12, Unknown 5, Not yet recruiting 2, Recruiting 2, Enrolling by invitation 1, Terminated 1, Withdrawn 1

Follow Peripheral Vascular Diseases: new trials by email Literature Review of Peripheral Vascular Diseases trials Research Report on Peripheral Vascular Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease
FGF-1, Placebo - Peripheral Arterial Disease, Stenosis
Phase 1 / Phase 2Not yet recruitingVenturis Therapeutics, Inc.242028-10-152026-08-19
Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion
Vitamin B6 25 MG, Vitamin B6 50 MG, Vitamin B6 100 MG - Ischemia Reperfusion Injury, Peripheral Artery Disease
Early Phase 1Not yet recruitingMilton S. Hershey Medical Center302027-12-012026-03-17
PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
Clinical Decision Aid, Standard Care - Heart Failure, Coronary Artery Disease
Not yet recruitingMedical College of Wisconsin602027-12-012026-11-03
Study to Image Inflammatory Activity of a Fluorescence Imaging Agent in Excised Human Artery Plaques
Pegulicianine, Placebo - Carotid Artery Diseases, Peripheral Arterial Disease
Early Phase 1Not yet recruitingMassachusetts General Hospital252027-06-012026-11-10
Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease
BOTOX INJECTION - Buerger Disease, Raynaud Syndrome
Phase 3Not yet recruitingUniversity Hospital, Toulouse82027-01-012026-07-23
Daily Stretching to Improve Walking in Older Patients With Peripheral Artery Disease: The STRETCH PAD Study
Therapeutic calf stretching, Sham calf stretching - Peripheral Artery Disease (PAD), Intermittent Claudication
Not applicableNot yet recruitingPenn State University3002027-01-012026-11-05
Drug-coated Balloons Versus Drug-eluting Stents for the Treatment of Femoropopliteal In-Stent Restenosis
Drug-Coated Balloon-First Strategy, Eluvia Drug-Eluting Stent-First Strategy - Femoropopliteal In-Stent Restenosis (ISR)
Not yet recruitingChunshui He6002027-01-012026-11-02
FRAME, External Support for Lower Limb Autologous Grafts
FRAME - Peripheral Arterial Disease, Peripheral Artery Disease
Not applicableSuspendedVascular Graft Solutions Ltd.302026-12-312025-02-04
Spectroscopic Assessment of Tissue Oxygenation Changes During Vascular Surgery
Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia
Not yet recruitingSpectrocor302026-12-012026-08-26
DCB Outcomes After Non-Compliant Balloon Vessel Preparation With or Without Scoring in Patients With Femoropopliteal Arterial Disease
Non-compliant Plain Balloon angioplasty (PBA), Non-compliant Scoring Balloon Angioplasty (SB) - Femoropopliteal Disease, Drug Coated Balloon
Not applicableNot yet recruitingMarc Sirvent1422026-12-012026-10-07
The NICE-PAD II Trial
Nicotinamide Riboside (NR), Placebo - Peripheral Artery Disease (PAD)
Phase 3Not yet recruitingNorthwestern University2502026-12-012026-08-24
XPAD European Feasibility Study
XPAD conduit - Peripheral Arterial Disease
Not applicableNot yet recruitingXeltis152026-12-012026-07-21
IV-X Medical Peripheral Intravascular Lithotripsy Study for PAD
IV-X Medical IVL System - Peripheral Artery Disease (PAD)
Not applicableNot yet recruitingIVX Medical1402026-12-012026-10-21
Perioperative Limb Oxygenation Monitoring in Patients With CLTI
Near-infrared spectroscopy (NIRS, Medtronic, INVOS) tissue oxygenation monitoring - Chronic Limb Threatening Ischemia, CLTI
Not applicableRecruitingBelarusian State Medical University1202026-11-022026-11-12
Hemodynamic Characteristics of Peripheral Arterial Disease Using Computational Fluid Dynamics
Computational Fluid Dynamics Simulation - Peripheral Arterial Disease
Not yet recruitingFudan University142026-11-012026-10-06
Emerging Indications for Hyperbaric Oxygen Treatment
Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis
Phase 4Not yet recruitingJay C. Buckey Jr.1002026-11-012026-09-09
Clinical Value of CT Perfusion in Peripheral Artery Disease
Peripheral Artery Disease (PAD), CT Perfusion
Not yet recruitingFudan University2002026-11-012026-09-14
A Bioequivalence and Safety Study of AJU-B718 and B718R in Healthy Adult Volunteers Under Fasting Conditions
Test Drug, Reference Drug - Peripheral Arterial Disease
Phase 1Not yet recruitingAJU Pharm Co., Ltd.402026-11-012026-10-28
REducing Systemic Inflammation With LOw-dose Colchicine to ImproVE Cardiovascular Calcification in Chronic Kidney Disease: A Pilot Randomized Open-Label Trial
Low-dose Colchicine at 0.5mg daily, Usual Care - Chronic Kidney Disease Mineral and Bone Disorder, Cognitive Function
Phase 2Not yet recruitingUniversity of Texas Southwestern Medical Center602026-10-302026-11-04
A Study of LIQ861 (Inhaled Treprostinil) in Adults With Systemic Sclerosis Who Have Symptomatic Raynaud's Phenomenon Attacks
LIQ861 (treprostinil) inhalation powder - Dose Titration Arm, LIQ861 (treprostinil) inhalation powder - fixed dose arm - Raynaud's Phenomenon Secondary to Systemic Sclerosis
Phase 2Not yet recruitingLiquidia Technologies, Inc.752026-10-262026-08-07

Showing 20 of 2075. Sign in to see all of them.

Narrower conditions

Peripheral Arterial Disease (1362)  ·  Chronic Limb-Threatening Ischemia (354)  ·  Intermittent Claudication (307)  ·  Atherosclerosis (127)  ·  Cardiovascular Diseases (121)  ·  Diabetes Mellitus (105)  ·  Raynaud Disease (80)  ·  Coronary Artery Disease (78)  ·  Arterial Occlusive Diseases (73)  ·  Vascular Diseases (68)  ·  Diabetic Foot (56)  ·  Stroke (50)  ·  Motor Activity (49)  ·  Ischemia (46)

Broader conditions

Vascular Diseases (2007)  ·  Cardiovascular Diseases (1954)  ·  Arteriosclerosis (1604)  ·  Arterial Occlusive Diseases (1566)  ·  Atherosclerosis (1481)  ·  Pathological Conditions, Signs and Symptoms (845)  ·  Pathologic Processes (523)  ·  Disease Attributes (392)  ·  Signs and Symptoms (383)  ·  Chronic Disease (380)  ·  Ischemia (380)  ·  Peripheral Arterial Disease (315)  ·  Endocrine System Diseases (182)  ·  Nutritional and Metabolic Diseases (182)

Interventions

Angioplasty (43)  ·  Aspirin (43)  ·  Exercise (37)  ·  Clopidogrel (36)  ·  Cilostazol (24)  ·  Rivaroxaban (20)  ·  Angioplasty, Balloon (18)  ·  Standard of Care (18)  ·  Stents (16)  ·  Atherectomy (14)  ·  Saline Solution (14)  ·  Sodium Chloride (14)  ·  Ticagrelor (13)  ·  Control Groups (11)  ·  Exercise Therapy (8)

Sponsors

Northwestern University (30)  ·  University Hospital, Angers (30)  ·  Medtronic Endovascular (24)  ·  Flanders Medical Research Program (22)  ·  Abbott Medical Devices (20)  ·  C. R. Bard (20)  ·  National Heart, Lung, and Blood Institute (NHLBI) (18)  ·  Spectranetics Corporation (16)  ·  VA Office of Research and Development (16)  ·  Cook Group Incorporated (15)  ·  Boston Scientific Corporation (14)  ·  W.L.Gore & Associates (14)  ·  University of Nebraska (13)  ·  Bayer (12)  ·  Biotronik AG (12)

Countries

United States (676)  ·  Germany (232)  ·  France (174)  ·  United Kingdom (121)  ·  China (120)  ·  Belgium (112)  ·  Italy (110)  ·  Austria (97)  ·  Canada (79)  ·  Netherlands (72)  ·  Spain (67)  ·  South Korea (54)  ·  Brazil (51)  ·  Switzerland (47)  ·  Australia (46)

Top investigators

Marc Bosiers, MD (16)  ·  Koen Deloose, MD (14)  ·  Thomas Zeller, MD (13)  ·  Mary McDermott, MD (12)  ·  Dierk Scheinert, MD (11)  ·  Gunnar Tepe, MD (9)  ·  Marianne Brodmann, MD (9)  ·  Andrew Holden, MD (8)  ·  Jihad Mustapha, MD (8)  ·  Subhash Banerjee, MD (6)  ·  Kenneth Rosenfield, MD (5)  ·  Mary M McDermott, MD (5)  ·  Pierre Abraham, MD, PhD (5)

Results publications

PMID 42573020, PMID 42035974, PMID 31567024, PMID 33025243, PMID 35802393, PMID 36588397, PMID 36645250, PMID 30690141, PMID 31543165, PMID 36137674, PMID 37929840, PMID 39968829, PMID 17223489, PMID 18272892, PMID 21262997, PMID 23583245, PMID 23915883, PMID 25237048, PMID 25472980, PMID 26062950, PMID 31926836, PMID 34167675, PMID 40260835, PMID 41159585, PMID 16242558, PMID 16449620, PMID 17140820, PMID 17848483, PMID 18779447, PMID 20484101, PMID 21123095, PMID 21146749, PMID 21622669, PMID 21873417, PMID 21953370, PMID 22169682, PMID 22429908, PMID 22878166, PMID 23050152, PMID 23192918, PMID 23797811, PMID 24402764, PMID 24402839, PMID 25499305, PMID 25908725, PMID 26476467, PMID 26490645, PMID 26861113, PMID 27388828, PMID 27840332

NIH funding

2009 (5), 2017 (4), 2005 (3), 2014 (3), 2023 (3), 2025 (3), 2019 (2), R01AG006244 (2), R01HL075774 (2), R01HL098909 (2), 1IK2RX003546-01A2 (1), 1RC2HL101515-01 (1), 2004 (1), 2008 (1), 2016 (1)